Abstract
Synthetic cathinones (SCs) represent an alternative to the prevailing array of drugs of abuse, with this being attributable to a variety of factors pertaining to reward /reinforcement potency, apparent but not necessarily lower toxicity risk, and easy access in “alternative” marketplaces. SCs retain distinctive neuropharmacological profiles and the induction of a disparate behavioral spectrum relating to locomotor activity, learning effectiveness, anxiety, thermoregulation, and abuse liability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aarde SM, Huang PK, Creehan KM et al (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130–140. https://doi.org/10.1016/j.neuropharm.2013.04.003
Aarde SM, Taffe MA (2017) Predicting the abuse liability of entactogen-class, new and emerging psychoactive substances via preclinical models of drug self-administration. Curr Top Behav Neurosci 32:145–164. https://doi.org/10.1007/7854_2016_54
Adamowicz P, Zuba D, Byrska B (2014) Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Sci Int 245:126–132. https://doi.org/10.1016/j.forsciint.2014.10.016
Alfaifi H, Abdelwahab SI, Mohan S et al (2017) Catha edulis Forsk. (Khat): evaluation of its antidepressant-like activity. Pharmacogn Mag 13(Suppl 2):S354–S358. https://doi.org/10.4103/pm.pm_442_16
Alvarez JC, Fabresse N, Larabi IA (2017) Prevalence and surveillance of synthetic cathinones use by hair analysis: an update review. Curr Pharm Des. https://doi.org/10.2174/1381612823666170704124156
Angoa-Pérez M, Anneken JH, Kuhn DM (2017) Neurotoxicology of synthetic cathinone analogs. Curr Top Behav Neurosci 32:209–230. https://doi.org/10.1007/7854_2016_21
Assi S, Gulyamova N, Ibrahim K et al (2017) Profile, effects, and toxicity of novel psychoactive substances: a systematic review of quantitative studies. Hum Psychopharmacol 32(3). https://doi.org/10.1002/hup.2607
Awadalla NJ, Suwaydi HA (2017) Prevalence, determinants and impacts of khat chewing among professional drivers in Southwestern Saudi Arabia. East Mediterr Health J 23(3):189–197
Barrios L, Grison-Hernando H, Boels D et al (2016) Death following ingestion of methylone. Int J Legal Med 130(2):381–385. https://doi.org/10.1007/s00414-015-1212-4
Baumann MH, Bukhari MO, Lehner KR et al (2017) Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs. Curr Top Behav Neurosci 32:93–117. https://doi.org/10.1007/7854_2016_53
Byrska B, Stanaszek R, Zuba D (2017) Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015. Drug Test Anal 9(8):1267–1274. https://doi.org/10.1002/dta.2151
Dolengevich-Segal H, Rodríguez-Salgado B, Gómez-Arnau J, Sánchez-Mateos D (2016) Severe psychosis, drug dependence, and hepatitis C related to slamming mephedrone. Case Rep Psychiatry 2016:8379562. https://doi.org/10.1155/2016/8379562
Drug Enforcement Administration, Department of Justice (2014a) Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I, Final Order. Fed Regist 79:12938–12943
Drug Enforcement Administration, Department of Justice (2014b) Schedules of controlled substances: extension of temporary placement of 10 synthetic cathinones into Schedule I of the Controlled Substances Act. Final order. Fed Regist 81:11429–11431
Gannon BM, Galindo KI, Mesmin MP et al (2017a) Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats. Neuropharmacology. pii: S0028–3908(17)30385–4. https://doi.org/10.1016/j.neuropharm.2017.08.018
Gannon BM, Galindo KI, Rice KC, Collins GT (2017b) Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats. J Pharmacol Exp Ther 361(1):181–189. https://doi.org/10.1124/jpet.116.239376
Giannotti G, Canazza I, Caffino L et al (2017) The cathinones MDPV and α-PVP elicit different behavioral and molecular effects following acute exposure. Neurotox Res. https://doi.org/10.1007/s12640-017-9769-y
Glennon RA, Dukat M (2017) Structure-activity relationships of synthetic cathinones. Curr Top Behav Neurosci 32:19–47. https://doi.org/10.1007/7854_2016_41
Grapp M, Kaufmann C, Ebbecke M (2017) Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): detection, quantification and studies on human metabolism by GC-MS. Forensic Sci Int 273:1–9. https://doi.org/10.1016/j.forsciint.2017.01.021
Gray R, Bressington D, Hughes E, Ivanecka A (2016) A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness. J Psychiatr Ment Health Nurs 23(5):267–281. https://doi.org/10.1111/jpm.12297
Grecco GG, Kisor DF, Magura JS, Sprague JE (2017) Impact of common clandestine structural modifications on synthetic cathinone “bath salt” pharmacokinetics. Toxicol Appl Pharmacol 328:18–24. https://doi.org/10.1016/j.taap.2017.05.010
Guirguis A, Corkery JM, Stair JL et al (2017) Intended and unintended use of cathinone mixtures. Hum Psychopharmacol 32(3). https://doi.org/10.1002/hup.2598
Hayashi K, Wakabayashi C, Ikushima Y, Tarui M (2017) High prevalence of quasi-legal psychoactive substance use among male patients in HIV care in Japan: a cross-sectional study. Subst Abuse Treat Prev Policy 12(1):11. https://doi.org/10.1186/s13011-017-0097-2
Huskinson SL, Naylor JE, Townsend EA et al (2017) Self-administration and behavioral economics of second-generation synthetic cathinones in male rats. Psychopharmacology 234(4):589–598. https://doi.org/10.1007/s00213-016-4492-6
Katz DP, Bhattacharya D, Bhattacharya S et al (2014) Synthetic cathinones: “a khat and mouse game”. Toxicol Lett 229(2):349–356. https://doi.org/10.1016/j.toxlet.2014.06.02
King HE, Riley AL (2017) The affective properties of synthetic cathinones: role of reward and aversion in their abuse. Curr Top Behav Neurosci 32:165–181. https://doi.org/10.1007/7854_2016_32
Lantz SM, Rosas-Hernandez H, Cuevas E et al (2017) Monoaminergic toxicity induced by cathinone phthalimide: an in vitro study. Neurosci Lett 655:76–81. https://doi.org/10.1016/j.neulet.2017.06.059
Matthews A, Sutherland R, Peacock A et al (2017) I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances. Int J Drug Policy 40:44–49. https://doi.org/10.1016/j.drugpo.2016.11.004
Matsuta S, Shima N, Kamata H et al (2015) Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine. Forensic Sci Int 249:181–188. https://doi.org/10.1016/j.forsciint.2015.02.004
Mekonen T, Fekadu W, Mekonnen TC, Workie SB (2017) Substance use as a strong predictor of poor academic achievement among university students. Psychiatry J. 2017:7517450. https://doi.org/10.1155/2017/7517450
Miller B, Kim J, Concheiro M (2017) Stability of synthetic cathinones in oral fluid samples. Forensic Sci Int 274:13–21. https://doi.org/10.1016/j.forsciint.2016.11.034
Nakajima M, Molla K, Belachew B et al (2017) Khat use is associated with tobacco, alcohol, and illicit drug use: a cross-sectional examination in the United States. J Psychoactive Drugs 49(5):413–419. https://doi.org/10.1080/02791072.2017.1342155
Naylor JE, Freeman KB, Blough BE et al (2015) Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats. Drug Alcohol Depend 149:280–284. https://doi.org/10.1016/j.drugalcdep.2015.02.002
Nguyen JD, Aarde SM, Cole M et al (2016) Locomotor stimulant and rewarding effects of inhaling methamphetamine, MDPV, and mephedrone via electronic cigarette-type technology. Neuropsychopharmacology 41(11):2759–2771. https://doi.org/10.1038/npp.2016.88
Palamar JJ, Acosta P, Sherman S et al (2016) Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. Am J Drug Alcohol Abuse 42(6):624–632. https://doi.org/10.1080/00952990.2016.1181179
Palamar JJ, Acosta P, Calderón FF et al (2017a) Assessing self-reported use of new psychoactive substances: the impact of gate questions. Am J Drug Alcohol Abuse 43(5):609–617. https://doi.org/10.1080/00952990.2017.1322094
Palamar JJ, Acosta P, Cleland CM (2017b) Attitudes and beliefs about new psychoactive substance use among electronic dance music party attendees. Subst Use Misuse 1–10. https://doi.org/10.1080/10826084.2017.1327980
Palamar JJ, Salomone A, Gerace E et al (2017c) Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene. Int J Drug Policy 48:91–98. https://doi.org/10.1016/j.drugpo.2017.07.010
Papaseit E, Moltó J, Muga R et al (2017) Clinical pharmacology of the synthetic cathinone mephedrone. Curr Top Behav Neurosci 32:313–331. https://doi.org/10.1007/7854_2016_61
Piacentino D, Kotzalidis GD, Longo L et al (2017) Body image and eating disorders are common among professional and amateur athletes using performance and image enhancing drugs: a cross-sectional study. J Psychoactive Drugs 49(5):373–384. https://doi.org/10.1080/02791072.2017.1359708
Pourmand A, Mazer-Amirshahi M, Chistov S et al (2018) Designer drugs: review and implications for emergency management. Hum Exp Toxicol 37(1):94–101. https://doi.org/10.1177/0960327117698542
Romanek K, Stenzel J, Schmoll S et al (2017) Synthetic cathinones in Southern Germany—characteristics of users, substance-patterns, co-ingestions, and complications. Clin Toxicol (Phila) 55(6):573–578. https://doi.org/10.1080/15563650.2017.1301463
Salomone A, Palamar JJ, Gerace E et al (2017) Hair testing for drugs of abuse and new psychoactive substances in a high-risk population. J Anal Toxicol 41(5):376–381. https://doi.org/10.1093/jat/bkx020
Schifano F, Orsolini L, Papanti D, Corkery J (2017) NPS: medical consequences associated with their intake. Curr Top Behav Neurosci 32:351–380. https://doi.org/10.1007/7854_2016_15
Schifano F, Papanti GD, Orsolini L, Corkery JM (2016) Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert Rev Clin Pharmacol 9(7):943–954. https://doi.org/10.1586/17512433.2016.1167597
Schmoll S, Romanek K, Stich R et al (2017) An internet-based survey of 96 German-speaking users of “bath salts”: frequent complications, risky sexual behavior, violence, and delinquency. Clin Toxicol (Phila). https://doi.org/10.1080/15563650.2017.1353094
Simmler LD, Liechti ME (2017) Interactions of cathinone NPS with human transporters and receptors in transfected cells. Curr Top Behav Neurosci 32:49–72. https://doi.org/10.1007/7854_2016_20
Simmler LD, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 152–160. https://doi.org/10.1016/j.neuropharm.2013.11.008
Simmons SJ, Gregg RA, Tran FH et al (2016) Comparing rewarding and reinforcing properties between ‘bath salt’ 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addict Biol. https://doi.org/10.1111/adb.12479
Smith KE, Bunting AM, Staton M et al (2017) Examination of synthetic cannabinoid and cathinone use among a drug-using offender sample, 2013–2015. J Psychoactive Drugs 49(5):436–445. https://doi.org/10.1080/02791072.2017.1361560
Stanciu CN, Penders TM, Gnanasegaram SA et al (2017) The behavioral profile of methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (PVP)—a systematic review. Curr Drug Abuse Rev. https://doi.org/10.2174/1874473710666170321122226
Stogner JM, Miller BL (2013) Investigating the ‘bath salt’ panic: the rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev 32(5):545–549. https://doi.org/10.1111/dar.12055
Styszko K, Dudarska A, Zuba D (2016) The presence of stimulant drugs in wastewater from Krakow (Poland): a snapshot. Bull Environ Contam Toxicol 97(3):310–315. https://doi.org/10.1007/s00128-016-1869-5
Sutherland R, Bruno R, Peacock A et al (2017) Motivations for new psychoactive substance use among regular psychostimulant users in Australia. Int J Drug Policy 43:23–32. https://doi.org/10.1016/j.drugpo.2016.12.021
Valente MJ, Araújo AM, Silva R et al (2016) 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Arch Toxicol 90(8):1959–1973. https://doi.org/10.1007/s00204-015-1653-z
Watterson LR, Olive MF (2017) Reinforcing effects of cathinone NPS in the intravenous drug self-administration paradigm. Curr Top Behav Neurosci 32:133–143. https://doi.org/10.1007/7854_2016_33
Wojcieszak J, Andrzejczak D, Woldan-Tambor A, Zawilska JB (2016) Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones. Neurotox Res 30(2):239–250. https://doi.org/10.1007/s12640-016-9640-6
Xu P, Qiu Y, Zhang Y et al (2016) The effects of 4-methylethcathinone on conditioned place preference, locomotor sensitization, and anxiety-like behavior: a comparison with methamphetamine. Int J Neuropsychopharmacol 19(4). pii: pyv120. https://doi.org/10.1093/ijnp/pyv120
Zona LC, Grecco GG, Sprague JE (2016) Cooling down the bath salts: carvedilol attenuation of methylone and mephedrone mediated hyperthermia. Toxicol Lett 263:11–15. https://doi.org/10.1016/j.toxlet.2016.10.012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Archer, T., Kostrzewa, R.M. (2018). Synthetic Cathinones: Neurotoxic Health Hazards and Potential for Abuse. In: Zawilska, J. (eds) Synthetic Cathinones. Current Topics in Neurotoxicity, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-78707-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-78707-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78706-0
Online ISBN: 978-3-319-78707-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)